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Abstract
Objective: Complementary and alternative medicine (CAM) is commonly used by children, but estimates of that use vary
widely partly due to the range of questionnaires used to assess CAM use. However, no studies have attempted to appraise
measurement properties of these questionnaires. The aim of this systematic review was to critically appraise and summarize
measurement properties of questionnaires of CAM use in pediatrics.
Study design: A search strategy was implemented in major electronic databases in March 2011 and conference websites,
scientific journals and experts were consulted. Studies were included if they mentioned a questionnaire assessing the
prevalence of CAM use in pediatrics. Members of the team independently rated the methodological quality of the studies
(using the COSMIN checklist) and measurement properties of the questionnaires (using the Terwee and Cohen criteria).
Results: A total of 96 CAM questionnaires were found in 104 publications. The COSMIN checklist showed that no studies
reported adequate methodological quality. The Terwee criteria showed that all included CAM questionnaires had
indeterminate measurement properties. According to the Cohen score, none were considered to be a well-established
assessment, two approached the level of a well-established assessment, seven were promising assessments and the
remainder (n=87) did not reach the score’s minimum standards.
Conclusion: None of the identified CAM questionnaires have been thoroughly validated. This systematic review highlights
the need for proper validation of CAM questionnaires in pediatrics, which may in turn lead to improved research and
knowledge translation about CAM in clinical practice.
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Introduction
According to the National Center for Complementary and
Alternative Medicine (NCCAM), complementary and alternative
medicine (CAM), includes many types of therapies and products
that are not considered to be part of conventional medicine [1].
NCCAM mentions four domains of complementary and alterna-
tive medicine: 1) natural products (e.g. vitamins, minerals, dietary
supplements, probiotics); 2) mind-body medicine (e.g. meditation,
yoga, acupuncture, deep-breathing exercises, guided imagery, tai
chi); 3) manipulative and body-based practices (e.g. spinal
manipulation, massage therapy); and 4) other CAM practices
(e.g. movement therapies, traditional healers, energy therapies)
[1]. Even though the NCCAM definition is widely known and
PLoS ONE | www.plosone.org 1 June 2012 | Volume 7 | Issue 6 | e39611used, there is no consensus on the definition of CAM [2] or the
types of therapies or products that should be considered as such
[3], which makes it difficult to collect data in a standardized
manner in both research and clinical settings. Thus, it remains
difficult to compare research from different studies and to ensure
a thorough assessment of CAM use in clinical practice. Since the
NCCAM definition is inclusive of many different types of therapies
and products, we will use it in the present article.
There is an increasing interest in CAM in pediatrics [4],
stressing the importance for health care providers to initiate
a dialogue about CAM use in order to assess its impact on their
lives and to provide the most up-to-date evidence-based advice on
risks and benefits of these therapies. While research has been done
in many pediatric populations, a recent systematic review of
prevalence of CAM use in pediatric cancer patients has
highlighted the lack of standardized methods and validated
questionnaires to assess patients’ use and perceptions of CAM in
this population [2]. Authors of that review urge the scientific
community to develop standardized, valid and comprehensive
CAM questionnaires. To date, no systematic review has assessed
the extent of measurement properties of CAM questionnaires in
pediatrics.
The objective of this systematic review was to critically appraise
and summarize the research evidence on the measurement
properties of questionnaires assessing the use of CAM in
pediatrics. To achieve this goal, we adapted the research protocol
for systematic reviews of measurement properties created by
Terwee et al. which includes steps such as evaluating the
methodological quality of the included studies and the content
and measurement properties of the instruments used in those
studies [5] (protocol shown in Appendix S1). The secondary
objective of this review was to inform the development of a valid
and reliable questionnaire assessing the use of CAM for
discriminative and evaluative purposes in pediatric clinical and
research settings (should one not already exist). We used the
PRISMA statement to help guide the reporting of the systematic
review (see completed PRISMA checklist in Appendix S2) [6].
Methods
Literature Search
An electronic search strategy (See Appendix S3) was developed
by a librarian (TR) and refined using the peer review of electronic
search strategies checklist [7]. The search strategy was implemen-
ted in the following electronic databases: MEDLINE (1950 to
week 12 2011), Healthstar, Cochrane CENTRAL, AMED (1985
to 2011), PsycINFO, The Cochrane Collaboration’s Methodology
Register, EMBASE (1980 to 2011) and the Health and Psycho-
social Instruments database (1985 to the last week of March 2011).
Conference websites, scientific journals and experts in the field of
CAM were also consulted in order to identify relevant publications
of CAM questionnaires.
Eligibility Criteria
Questionnaires were included if they sought to assess the
prevalence of a wide range of CAM use (more than one type or
one sub-category of CAM), such as products and services provided
by CAM practitioners, in pediatric patients (age 18 years and
younger), and if they were reported in English or French language
articles. All types of studies (e.g. psychometric studies, prevalence
studies and clinical trials) were included if they reported using such
a questionnaire. Grey literature, such as abstracts published in
scientific journals or proceedings of conferences were excluded due
to lack of information concerning questionnaires used. Results
from our search were exported into a Reference Manager
database.
Identification of Studies
Two members of the team (KTA and AB or BD) independently
screened identified titles, abstracts and key words for relevance,
and assessed potentially relevant studies for inclusion according to
our eligibility criteria. Full text articles of records meeting the
screening criteria were obtained. Each reviewer then decided
independently which articles met the eligibility criteria and should
be included in the systematic review. Disagreements were resolved
by discussion with a third member of the team (JS or DM). If some
data from the studies were insufficient or missing, we attempted to
obtain this information from the authors by personal communi-
cation (email) up to three times.
Data Extraction Procedures
Data from included studies were independently extracted by
three members of the team using the previously piloted data
extraction form (KTA and MW or AB) and then entered into an
Excel spread sheet. The extracted data included: characteristics of
the studies (study design, objectives, geographical location, target
population) and the questionnaires (purpose, child and/or proxy
report, content, time to complete). The time to administer a tool
was documented and rated as 1) short if it took less than 10
minutes, or 2) long if it took more than 10 minutes to complete [8].
The methodological quality of studies reporting each CAM
questionnaire as well as the measurement properties of the CAM
questionnaires themselves were assessed. When data were missing
from a study, corresponding authors were e-mailed (two attempts)
in an effort to obtain questionnaires and additional information.
Authors were also e-mailed at the end of our systematic review in
order to confirm results.
Assessment of the methodological quality of the
studies. The methodological quality of the measurement
property testing reported in the included studies was assessed
using the COSMIN checklist (See Appendix S4) which is
a validated tool that has been used to rate studies reporting
measurement properties of health status measurement instruments
[9–12]. The checklist includes the following properties: content,
construct and criterion validity, test-retest, inter-rater, intra-rater
reliability and measurement error, internal consistency and
responsiveness (See definitions in Appendix S4) [11]. Interpret-
ability and generalisability of studies can also be rated. The quality
of each of the properties reported in a study is assessed by a series
of items including design requirements and preferred statistical
methods and can vary from excellent to poor depending on the
information reported by the authors. A total score is determined
by taking the lowest rating of the items for each measurement
property.
Assessment of the measurement properties of the CAM
questionnaires. We used the Terwee criteria [13] and the
Cohen score [14] to assess measurement properties of the CAM
questionnaires. Terwee et al. propose quality criteria for rating
measurement properties [13]. Whereas the COSMIN checklist
assesses the quality of the methods used in studies to validate
a questionnaire, the Terwee criteria evaluate the results stemming
from such studies. Validity, reliability, responsiveness, floor and
ceiling effects and interpretability can be rated as positive, negative
or indeterminate depending on the results of validation studies.
Criterion validity was not applicable for CAM questionnaires since
there is no gold standard to assess its use. Floor and ceiling effects
were not applicable for items rated on a nominal scale such as
CAM use, but could have been assessed for items which were rated
Pediatric Complementary Medicine Questionnaires
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applicable to CAM questionnaires since they did not provide
a total score.
The Cohen criteria [14] (Shown in Appendix S5) seek to
evaluate the degree of testing of measurement properties as well as
the dissemination and description of the questionnaires. The
Cohen criteria are divided into three levels depending on the
number of publications describing the questionnaires, the extent to
which questionnaires are described and their measurement
properties.
Synthesis
We completed a narrative summary of the included studies.
Content analysis was used to study the content of the included
articles. Descriptive statistics were used to describe the character-
istics of the studies and questionnaires.
Results
Search Results
The electronic search provided a total of 476 records after
eliminating duplicates. Additional consultation of conference
websites, scientific journals and experts in the field of CAM
yielded another 107 records. From these 583 unique potentially
relevant records, 104 met the screening criteria. We included 104
articles in the systematic review which summarized 100 studies
from which 96 CAM questionnaires were identified (see Figure S1
for a flow diagram of included studies and Appendix S6 for a list of
references for the included studies). Among authors of included
studies, 69 (69/96=71.9%) responded to our query by providing
additional information on their questionnaires’ measurement
properties. Some of these authors no longer had access to
questionnaires and a total of 50 authors ultimately provided copies
for this review. Although we did not receive questionnaires from
all authors, six CAM questionnaires were displayed in their
respective publications and one was found online. After complet-
ing our review, 51 (51/96=53.1%) authors confirmed our
appraisal of their studies and questionnaires, nine of them gave
new information that did not modify our assessment and one
author gave us new information that modified our assessment of
their questionnaire [15].
Characteristics of the Studies
Included studies sought to assess children’s use of CAM
(n=100), perceptions regarding children’s use of CAM (n=86)
and attitudes towards CAM in general (n=33). Most studies were
cross-sectional surveys of CAM use (n=98) and only two assessed
CAM use longitudinally [16;17]. Only 58 studies provided
a definition of what they considered to be CAM and definitions
varied tremendously. The most common definition was the
NCCAM definition (n=18 studies) [1].
Studies were conducted in 19 countries, the most common
being the United States (n=35), United Kingdom (n=15),
Canada (n=11), Australia (n=8), Turkey (n=6), Israel (n=3),
Ireland (n=2), Germany (n=2), Switzerland (n=2) and New
Zealand (n=2). Three studies did not disclose precisely where they
were conducted and three studies were conducted in multiple
countries. Studies were conducted in general pediatrics (n=24), in
specific pediatric conditions (n=63), such as cancer (n=19),
neurological (n=16), respiratory (n=11), gastrointestinal [5],
rheumatologic (n=4), dermatologic (n=3), haematological
(n=2), metabolic (n=2) and otolaryngological conditions (n=1),
as well as in both general pediatrics and specific diseases (n=5).
Other studies also assessed CAM use in children undergoing
surgical procedures (n=2), children with a range of diverse
chronic diseases (n=3) or acute illnesses (n=2) as well as homeless
youth (n=1).
Characteristics of the CAM Questionnaires
All included CAM questionnaires sought to discriminate
between users and non-users of CAM (i.e. discriminative purpose)
and none were reported to be designed to assess changes in CAM
use over time (evaluative purpose). Thirty nine percent (n=37) of
the questionnaires assessed disease-specific CAM use while 42%
(n=40) assessed the use of CAM in a general pediatric population
without referring to a specific disease, and one questionnaire
assessed both current disease-related use as well as use for other
reasons. Other questionnaires were not described in enough detail
to determine whether they were generic or disease-specific (n=18,
19%). Most questionnaires were targeted at parents, while 23% of
questionnaires gathered children and adolescent self-reports and
only two studies mentioned using a questionnaire specifically
designed to gather children and adolescents self-report. Children
completed questionnaires on their own beginning at 10 years of
age while children as young as seven years helped their parents to
answer the questions.
The content of the questionnaires varied considerably. The
number of types of CAM listed in questionnaires ranges from 3 to
161, some questionnaires listing only broad categories of CAM
(n=7) and others presenting an exhaustive list of herbal products,
vitamins and minerals. CAM types and categories were often not
adequately reported by studies and their diversity made it difficult
to synthesize the data. Questionnaires also included a wide range
of domains and items linked to CAM use (see Figure S2). The most
common domains and items were: reasons for CAM use (n=61,
63.5%), helpfulness (n=58, 60.4%), communication with health
providers concerning CAM (n=51, 53.1%), source of information
about CAM (n=48, 50%), CAM use by parents/family (n=40,
41.7%) and costs of CAM (n=38, 39.6%).
Concerning ease of use of the questionnaires, only ten were
reported to have a completion time under 10 minutes and the
others were reported to take up to 60 minutes to complete. A
summary of the characteristics of questionnaires tested for
measurement properties is shown in Table S1.
Methodological Quality of the Studies
Using the COSMIN checklist assessment, none of the studies
showed adequate methodological quality. Of the 11 questionnaires
which were mentioned to have been tested for content validity
[18–28], no studies were descriptive enough to reach the
COSMIN criteria. Most of the publications (82%) describing
those questionnaires did not mention whether items refer to and
comprehensively represent relevant aspects of the construct to be
measured. They also did not state whether items are relevant for
the population surveyed or for the purpose of the questionnaire.
Two CAM questionnaires [20;21] had their content validity
assessed by both patients and experts, which is an advantage
[13;29], while the other nine had it assessed by either patients
(n=2) or experts (n=7).
Three CAM questionnaires were assessed for construct validity
[15;30;31] but none were adequately reported. Most authors did
not provide information on missing items, a priori hypotheses
regarding the direction and magnitude of correlations, comparator
instrument, sample size and statistical analyses. Authors of one
study reported a small sample size (n=25 patients) and the use of
Spearman correlation coefficients by means of personal commu-
nication [15].
Pediatric Complementary Medicine Questionnaires
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assessed for test-retest reliability [15;30;32;33], inter-rater re-
liability [30] or internal consistency [15], none was described in
enough detail to meet the COSMIN criteria. Most of the
publications describing those questionnaires did not report how
missing items were handled and how repeated measurements were
conducted (mode of administration, sample size, statistical analyses
and time interval for test-retest). Some questionnaires were also
tested with long delays between first and second administration (4
to 6 weeks), different modes of administration between test and
retest, small sample size and inadequate statistical analyses. One
questionnaire [15] showed variable levels of test-retest agreement
using intraclass correlation coefficients as well as internal
consistency using Cronbach’s alpha (data provided by authors
by means of a personal communication).
Measurement Properties of CAM Questionnaires
When evaluating the quality of measurement properties for
each of the 96 included CAM questionnaires using the Terwee
criteria, none was rated as thoroughly valid. No questionnaire
reported an assessment of floor and ceiling effects. Only 16 CAM
questionnaires were assessed for one or more of the following
properties: content validity, and test-retest and inter-rater re-
liability (See summary characteristics of the most promising
questionnaires in Table S1).
Ratings for content validity were indeterminate since question-
naires were not reported to have used appropriate methods (e.g.
purposeofthequestionnaire,conceptstomeasure,involvementofthe
targetpopulation,methodsofitemselectionandreduction).Noneof
theincludedquestionnairesdescribedtheirprecisepurpose(whether
they are discriminative, evaluative or predictive) of the question-
naires. Measured concepts were often listed but not in a thorough
manner. Only two questionnaires [22;25] were reported to be
comprehensive (i.e. including all relevant items) and have involved
the target population of patients. One showed a high level of
agreement between experts ratings for included items [22].
Construct validity was rated as indeterminate for the three
questionnaires [15;30;31]. The domain scores of one questionnaire
were compared with measures of parental discipline and spiritual
practice/beliefs, which yielded Spearman’s correlation coefficients
ranging from 20.52 (p,0.01) to 0.34 (p=0.11) [15]. The results
of the second questionnaire were contrasted with medical and
nursing notes documenting CAM use for inpatients [30], while
findings from the third questionnaire were evaluated against CAM
products found in patients’ homes [31]. The indeterminate rating
was granted for each of these because correlation coefficients were
not presented, not strong enough or not provided for all domains
of the questionnaire.
All ratings for the four questionnaires [15;30;32;33] having
assessed test-retest reliability were indeterminate because the
majority did not present agreement coefficients such as Intraclass
correlation coefficient or Kappa coefficients or confidence
intervals. One of these questionnaires [15] presented variable
scores of agreement depending on the item (Intraclass correlation
coefficients between 0.52 to 0.78), which ranges from a negative to
a positive rating, which amounted to an indeterminate rating. The
same questionnaire also showed poor to questionable levels of
internal consistency (a=0.28 to 0.64). Inter-rater reliability was
also indeterminate for the only questionnaire having assessed it
(because the percentage of CAM use according to the different
raters was reported but not the agreement between raters) [30].
According to the Cohen score, no questionnaire was considered
to be a well-established one, two approached the level of a well-
established assessment [33;34] and seven were promising assess-
ments [18;19;21;22;24;28;35]. The remainder (n=87) were either
not described enough in publications (and the questionnaires not
provided in the publication nor available upon request to the
author) or their measurement properties were not reported at all.
(See summary characteristics of the most promising questionnaires
in Table S1).
Finally, among all included questionnaires, 19 were reported to
have good readability/comprehension but only one of them using
proper testing. This questionnaire was assessed using the Flesch-
Kincaid grade reading level (score=5.7), a test designed to
indicate comprehension difficulty and based on two core measures
(word and sentence length).
Discussion
To the best of our knowledge, this systematic review is the first
to formally aggregate the research evidence on the measurement
properties of questionnaires assessing the use of CAM in
pediatrics. This work will help to better understand the use of
CAM in various pediatric clinical and research settings by
informing future validation studies of CAM questionnaires. It will
also help clinicians, researchers and the general public to better
appraise the scientific literature on CAM in pediatrics.
The results of the current review suggest that many studies,
mostly cross-sectional and conducted in the United States, have
used CAM questionnaires to identify and understand the use of
CAM among pediatric populations. However, CAM question-
naires varied greatly in terms of their characteristics. Some were
disease-specific while others were generic, which may reflect that
both types of instruments are seen as helpful in order to
understand the use of CAM by researchers. Some succeed in
targeting specific types of CAM used by patients with a certain
condition while others have the advantage of assessing the use of
CAM in many different conditions as well as the public at large,
making it easier to compare use in different populations. Most of
the questionnaires targeted parents and very few mentioned using
a questionnaire specifically designed to gather children and
adolescents self-report, which may be important to use in order
to gather valid data about CAM use according to children. Such
a self-report questionnaire may provide researchers with a valid
tool to compare children’s and parents’ perceptions, which may
lead to changes in the way health care providers discuss CAM with
families. The high variability in the content of CAM ques-
tionnaires was also problematic and may explain great variability
in use in the pediatric studies, such as in cancer care [2]. This may
be explained by the fact that there is no consensus on a definition
of CAM and the therapies that it encompasses as well as items that
should be assessed in order to understand thoroughly the use of
CAM [36;37]. Very few questionnaires were reported to have
a completion time under 10 minutes, which might pose a problem
if used in a research setting and routine clinical practice.
Studies included in our review were judged to be of poor
methodological quality when evaluated by the COSMIN checklist
since methods used to test measurement properties of CAM
questionnaires were not described in enough detail to reach pre-
defined criteria. Poor methodological quality of the studies may be
explained by the fact that none of them were specifically designed
to validate a CAM questionnaire, but rather sought to describe the
use of CAM in specific populations. However, in order to do this,
questionnaires still need to meet validity and reliability criteria and
be described in a comprehensive manner.
None of the included CAM questionnaires met the Terwee
criteria for measurement properties. The lack of thoroughly valid
CAM questionnaires may be explained by the relative novelty of
Pediatric Complementary Medicine Questionnaires
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of funding provided to do such research, especially before the
creation of various funding agencies in the early 1990’s such as the
National Center for Complementary and Alternative Medicine
(NCCAM) in the United States [38]. Moreover, funding agencies
as well as the general public have been interested primarily in
evaluating CAM use in specific populations possibly because it was
most needed data to show the relevance of research in CAM.
Furthermore, conducting validation studies takes time, money and
energy, which may explain why researchers often engage in studies
without using properly validated tools, even in fields other than
CAM [39]. However, the fact that CAM questionnaires are not
valid is a problem since results may not reflect the true use of
CAM when such therapies are not clearly and comprehensively
defined and presented to parents and children. An international
CAM questionnaire was developed for adults and is currently
being validated [40] but results may be difficult to extrapolate to
children since perceptions concerning CAM may differ in these
two populations [41]. Our results highlight the need for further
research on defining and conceptualising CAM as well as
developing valid questionnaires of its use, especially in pediatrics.
Using a research protocol similar to Terwee et al., helped to
ensure credibility of our findings. However, the protocol as well as
the COSMIN checklist and the Terwee score have been used for
health status measures and not for CAM questionnaires. Because
CAM questionnaires have been less extensively studied than
health status measures, we encountered several difficulties in
applying the same criteria. For example, the COSMIN checklist
evaluates the methodological quality of validation studies, which
were not conducted in CAM research and rendered parts of our
assessment less pertinent. Furthermore, quality of reporting was
very poor in CAM studies, which we tried to counteract by
communicating with authors. Unfortunately, many did not reply
and some replied without giving more details than their published
work, which precludes us from knowing exactly how they
proceeded to ensure their CAM questionnaires were adequate.
Despite these limitations, we feel that currently available measures
are inadequate and a new questionnaire is required.
In conclusion, our systematic review showed that many surveys
have been conducted to document and understand the use of
CAM in pediatrics without having properly validated their tools.
Such tools, if valid, may prove to be useful in pediatric clinical
settings to document the use of CAM as well as their perceived
benefits and harms. This study highlights the need for research to
define and conceptualise CAM as well as develop valid ques-
tionnaires of its use. Such tools may in turn lead to improved
research and knowledge translation about CAM benefits and
harms in clinical practice.
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